Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

OSTEOARTHRITIS · CHAPTER 10

Living with Osteoarthritis: Is Your Plan Still Helping?

Track pain, swelling and daily activities separately—and know when the plan needs to change.

Olga Goodman, MD
Rheumatology in Perspective · by Olga Goodman, MD · A RheumaView publication
Evidence reviewed: September 28, 2026

My follow-up plan
On this page

1. A follow-up visit should lead to a useful decision

“Better” can mean several things: less pain, less swelling, easier dressing, a longer walk or fewer unwanted effects from treatment. These changes do not always happen together.

You do not need a perfect score to benefit from care. Choose an activity that matters to you and describe what prevents it. The aim of a review is to decide what to keep, what to adjust and what needs another explanation—not simply to repeat the prescription. The personal sheet at the end helps prepare that conversation; it is not a diagnostic test.

2. Do not wait for a routine visit for these changes

Get urgent assessment for a newly hot, very painful, rapidly swollen joint. Infection is possible even without fever, and finding crystals does not rule it out. Do not assume this is your usual flare or arrange another injection without assessment. [12]

Seek emergency care for new trouble emptying your bladder, numbness around the groin or buttocks, or rapidly worsening weakness with a concerning back/leg problem. Sudden inability to use a limb after injury also needs prompt assessment. [13, 1]

Vomiting blood, black stools with illness or weakness, severe breathing difficulty, or marked confusion/sleepiness after medication needs urgent medical help. A treatment diary is for routine review, not for waiting out a possible serious adverse effect. [17, 19]

3. Keep five kinds of information separate

Record pain during a familiar activity and whether it interrupts sleep. Record swelling or warmth and when it occurred. Record function: what you can do, for how long and with what help. Note sleep, fatigue and participation. Finally, record treatment effort and unwanted effects.

A useful note is: “My knee hurts less, but I still stop walking because my other foot hurts.” That is more informative than a single “no better.” You can use an optional pain number consistently, but you do not need to turn daily life into continuous monitoring.

This five-part record is an original conversation aid, not a medical scoring system. Research also treats pain, function and overall wellbeing as distinct outcomes. [3]

4. Compare the same task, not just two numbers

Choose a small, meaningful task: fastening a shirt, walking to the corner, standing to prepare lunch or using a keyboard. Note the date, assistance, rest breaks and relevant medicines.

Try to compare similar conditions. Walking farther with an appropriate aid can be real progress. Less pain only because you stopped the activity tells a different story. A new chair or another painful joint may change a performance test.

Clinical questionnaires use particular wording and scoring. Do not change a questionnaire and assume the resulting number means the same thing. Our sheet is not a translated version of a licensed questionnaire and has no pass/fail result. [5, 7, 8]

5. Less swelling and less pain are not identical

An X-ray description of erosions describes structural changes; it is not a live measure of inflammation. Swelling that settles may leave restricted movement or another source of discomfort. Equally, new persistent swelling may need a fresh assessment rather than more of the old treatment. [10, 14]

Explain the location and timing. A photograph taken during an episode may help show what changed, but it does not replace an examination or identify the cause by itself. You do not need to upload photographs or medical records to use this chapter.

6. When treatment has not helped enough

Bring the actual plan, not just the name of a treatment. What medicine or device did you use? How often? What did the exercise involve? Was it affordable and practical? Did you stop because it hurt, caused side effects, was confusing or was difficult to obtain?

These are reasons to improve the plan, not evidence that you were a “bad patient.” Treatment can also target the wrong problem. A thumb support cannot be expected to solve numbness from a nerve problem, and a knee treatment may not remove pain coming from elsewhere.

Ask: “What was this supposed to improve, what actually changed, and what should we do next?”

7. Agree how follow-up will happen

Some people can manage a stable plan and request review when needed. Others benefit from scheduled visits, especially when medicines need monitoring or it is difficult to seek help. There is no single OA appointment interval suitable for everyone. [1, 2]

Before leaving, record the review date or trigger, how to contact the team and who will discuss test results. A safety blood test may be needed earlier than the visit that checks whether rehabilitation is helping.

Contact the team sooner when the plan is not working within the agreed time, is not manageable or causes new problems. Waiting for a crisis is not a requirement.

8. Your other conditions and all medicines belong in the plan

Bring an up-to-date list of tablets, gels, injections, supplements and nonprescription products. Different brands can contain the same type of pain medicine. A topical anti-inflammatory gel is not automatically safe to combine with an oral anti-inflammatory. [17]

Kidney disease, heart or blood-pressure problems, bleeding risk and diabetes can change treatment choices. Dehydration from vomiting or diarrhea can make an old NSAID plan unsafe. Arrange individual instructions for illness in advance; do not independently stop every heart or blood-pressure medicine. [16]

A steroid injection may temporarily raise blood glucose. Ask what to monitor and what result should prompt contact. Do not stop prescribed anticoagulants yourself before a procedure. [18]

Some medicines have a role for one joint pattern or another disease but not for OA everywhere. An article saying that a drug is not recommended for OA is not an instruction to stop it when it treats another condition. [22]

9. Make movement fit the whole person

A sustainable plan needs a starting amount, a way to progress and an adjustment when circumstances change. Activity advice should take account of individual ability and barriers, rather than demand the same program from everyone. [20]

Explain when one joint prevents helping another: painful hands may make a walking aid hard to grip; a foot problem may limit a walking program; shoulder limitations may make chair transfers difficult. The answer may be a different aid, different exercise or practical therapy—not abandoning movement.

After an illness or flare, discuss a manageable restart. Do not push through new weakness or an unexplained hot, swollen joint to meet an exercise target.

10. Sleep and fatigue deserve attention too

Tell the team when poor sleep, fatigue or the effort of coping becomes a major part of the problem. These symptoms should not be dismissed as unimportant or used to imply that the pain is imaginary.

In a trial involving older adults with OA pain and insomnia, a structured telephone treatment for insomnia improved sleep and fatigue over follow-up. Its early pain advantage did not persist at one year. Sleep care can therefore be valuable without being a treatment that repairs cartilage. [21]

Record whether treatment leaves you clearer and more capable—or too sleepy to function safely.

11. Repeated procedures and reducing treatment need review

For an injection, record the joint, date, meaningful benefit, duration and unwanted effects. “I managed stairs for several weeks” is more useful than “I had an injection.” Tell the team about planned surgery before another injection. [18]

When a medicine or procedure no longer helps enough, review it rather than continuing automatically. Some medicines need gradual reduction. Do not abruptly stop a long-term opioid or invent a taper yourself. A supported plan can address pain and withdrawal safety together. [19]

Using fewer treatments can be a positive decision when it reduces burden without sacrificing useful benefit. It should be a planned change, not loss of access to care.

12. More scans do not always mean better follow-up

You do not need a repeat X-ray simply to prove that you feel better. Imaging is most useful when it can answer a question that changes treatment—for example, an unexpected deterioration or a surgical decision. [11]

Medication-safety tests answer another question. A normal kidney or blood-count result does not prove that a pain treatment works; a good pain response does not remove the need for safety checks.

Ask: “What decision will this test help us make?”

13. When a surgical discussion becomes useful

Continuing severe limitation deserves a reassessment, not endless repetition of the same ineffective plan. A surgical consultation can clarify the likely benefit, risks and recovery; it does not commit you to an operation.

For selected people who already have an appropriate hip/knee surgical indication and have chosen replacement after unsuccessful nonsurgical care, professional guidance advises against delay simply to repeat more of the same treatments. Preparation for diabetes, nicotine use and other risks is a separate issue. [24]

Discuss practical recovery needs early, including stairs, transport, help at home and whether other painful joints will affect walking aids or transfers.

14. Three examples for the next appointment

“The pain is lower, but I am sleepy and unsteady.” Report the adverse effects. A lower score is not the only goal.

“My fingers are less swollen, but buttons are still difficult.” Bring the task to the review. Movement or practical assistance may need its own plan.

“I have several treatments, but no one has said when to reassess.” Ask for one coordinated plan and clear responsibility. Your time and treatment effort count too. [25]

These examples illustrate questions to raise. They do not identify your diagnosis or tell you to change a dose.

15. My follow-up plan

Record the baseline and the present situation, then the actions already agreed with your care team. Printing keeps a copy for your next visit. You may leave any field blank and do not need to enter your name or identifying details.

The goal is a plan that remains useful, safe and workable—not a perfect pain score or a growing list of treatments.

My osteoarthritis follow-up record

Olga Goodman, MD · RheumaView · OSTEOARTHRITIS · CHAPTER 10

Your notes stay in this open page only. They are not transmitted or saved after you close or reload it. Print the plan to keep a copy. Record actions already agreed with your treating team; this form does not prescribe treatment. Changing language does not translate your notes.

A personal record, not a diagnostic score or an automatic prescription.

Sources
  1. NICE NG226. Osteoarthritis in over 16s: diagnosis and management—recommendations. — 2022; current page checked 2026-09-28.
  2. NICE NG226. Rationale and impact—follow-up and review. — 2022.
  3. Smith et al. OMERACT–OARSI core domain set for hip and knee OA clinical trials. — 2019.
  4. OARSI. Physical performance measures. — Official resource checked 2026-09-28.
  5. KOOS/HOOS/FAOS. Instrument access and copyright. — Official resource checked 2026-09-28.
  6. HealthMeasures. Obtaining and administering PROMIS measures and translations. — Official resource checked 2026-09-28.
  7. Kortekaas et al. Association of inflammation with development of erosions in hand OA. — Online 2015; issue February 2016.
  8. Sakellariou et al. EULAR recommendations for imaging in peripheral joint OA. — 2017.
  9. Ravn et al. Guideline for management of septic arthritis in native joints (SANJO). — 2023.
  10. NICE NG127. Suspected neurological conditions—adult recognition and referral. — 2019; current recommendations checked 2026-09-28.
  11. NICE NG100. Rheumatoid arthritis in adults—referral and investigations. — 2018; updated 2020.
  12. NIDDK. Keeping kidneys safe: smart choices about medicines. — Last reviewed June 2018; checked 2026-09-28.
  13. DailyMed. Diclofenac sodium topical gel, 1%—prescribing information. — Label checked 2026-09-28.
  14. Uson et al. EULAR recommendations for intra-articular therapies. — 2021.
  15. CDC. Clinical practice guideline for prescribing opioids for pain. — 2022.
  16. Rausch Osthoff et al. EULAR physical activity recommendations: 2025 update. — Online April 26, 2026; June 2026 issue.
  17. McCurry et al. Telephone CBT for insomnia in older adults with OA pain. — 2021.
  18. American College of Rheumatology. 2026 OA guideline summary. — Posted September 14, 2026.
  19. Hannon et al. ACR/AAHKS optimal timing of elective hip or knee arthroplasty. — 2023.
  20. NICE NG56. Multimorbidity: clinical assessment and management. — 2016; checked 2026-09-28.

Educational information from the author’s personal site. This is not a clinic portal, medical advice for an individual, or a way to send a message to your treating team. Private expert services, when offered, are paid directly and are not billed to insurance.

Back to top

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: osteoarthritis